Phase 1 first-in-human study of the enhancer of zeste-homolog 2 (EZH2) histone methyl transferase inhibitor E7438

Date 03 March 2015
Event 13th International Congress on Targeted Anticancer Therapies
Session Epigenetics and chaperones
Topics Anti-Cancer Agents & Biologic Therapy
Drug Development
Presenter Vincent Ribrag